GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...
The World Health Organization has backed GLP-1 medications for the treatment of obesity, which some advocates hope will open up access for th ...
Researchers found that older adults with diabetes who used semaglutide had more than twice the risk of developing a serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results